Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica

Background: Type 2 diabetes, hypertension and serum lipid abnormalities are common among obese people and they should improve with weight reduction. Aim: To study the outcome of these abnormalities after bariatric surgery in morbid obesity patients. Material and methods: Two hundred thirty two morbi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Papapietro V,Karin, Díaz G,Emma, Csendes J,Attila, Díaz J,Juan Carlos, Braghetto M,Italo, Burdiles P,Patricio, Maluenda G,Fernando, Rojas C,Jorge
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2005
Materias:	Diabetes Mellitus, type 2 Gastric bypass Obesity, morbid
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000500001
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872005000500001
record_format	dspace
spelling	oai:scielo:S0034-988720050005000012005-06-17Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátricaPapapietro V,KarinDíaz G,EmmaCsendes J,AttilaDíaz J,Juan CarlosBraghetto M,ItaloBurdiles P,PatricioMaluenda G,FernandoRojas C,Jorge Diabetes Mellitus, type 2 Gastric bypass Obesity, morbid Background: Type 2 diabetes, hypertension and serum lipid abnormalities are common among obese people and they should improve with weight reduction. Aim: To study the outcome of these abnormalities after bariatric surgery in morbid obesity patients. Material and methods: Two hundred thirty two morbid obese patients subjected to gastric bypass, were evaluated in the preoperative period and every three months after surgery, during a minimum of 12 months. Clinical evolution, blood glucose, serum insulin, insulin resistance measured with the homeostasis model assessment (HOMA) and serum lipid levels were analyzed. Results: In the preoperative period, 17% had type 2 diabetes, 49% had abnormal serum lipid levels and 25% had high blood pressure. Sixty six percent had at least one of these abnormalities and 20% had more than one. During follow up, body mass index decreased from 44 to 29.3 kg/m2. Total and HDL cholesterol, blood glucose and insulin resistance significantly decreased from the third month after surgery. Diabetes disappeared in 97% of diabetic subjects, blood pressure normalized in 53% of subjects with hypertension and serum lipid levels returned to normal in 88% of subjects with dyslipidemia. Conclusions: Gastric bypass in morbid obese patients achieves a significant and important weight reduction that results in significant reductions in the frequency of diabetes, dyslipidemia and hypertension among operated obese subjectsinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.133 n.5 20052005-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000500001es10.4067/S0034-98872005000500001
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Diabetes Mellitus, type 2 Gastric bypass Obesity, morbid
spellingShingle	Diabetes Mellitus, type 2 Gastric bypass Obesity, morbid Papapietro V,Karin Díaz G,Emma Csendes J,Attila Díaz J,Juan Carlos Braghetto M,Italo Burdiles P,Patricio Maluenda G,Fernando Rojas C,Jorge Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica
description	Background: Type 2 diabetes, hypertension and serum lipid abnormalities are common among obese people and they should improve with weight reduction. Aim: To study the outcome of these abnormalities after bariatric surgery in morbid obesity patients. Material and methods: Two hundred thirty two morbid obese patients subjected to gastric bypass, were evaluated in the preoperative period and every three months after surgery, during a minimum of 12 months. Clinical evolution, blood glucose, serum insulin, insulin resistance measured with the homeostasis model assessment (HOMA) and serum lipid levels were analyzed. Results: In the preoperative period, 17% had type 2 diabetes, 49% had abnormal serum lipid levels and 25% had high blood pressure. Sixty six percent had at least one of these abnormalities and 20% had more than one. During follow up, body mass index decreased from 44 to 29.3 kg/m2. Total and HDL cholesterol, blood glucose and insulin resistance significantly decreased from the third month after surgery. Diabetes disappeared in 97% of diabetic subjects, blood pressure normalized in 53% of subjects with hypertension and serum lipid levels returned to normal in 88% of subjects with dyslipidemia. Conclusions: Gastric bypass in morbid obese patients achieves a significant and important weight reduction that results in significant reductions in the frequency of diabetes, dyslipidemia and hypertension among operated obese subjects
author	Papapietro V,Karin Díaz G,Emma Csendes J,Attila Díaz J,Juan Carlos Braghetto M,Italo Burdiles P,Patricio Maluenda G,Fernando Rojas C,Jorge
author_facet	Papapietro V,Karin Díaz G,Emma Csendes J,Attila Díaz J,Juan Carlos Braghetto M,Italo Burdiles P,Patricio Maluenda G,Fernando Rojas C,Jorge
author_sort	Papapietro V,Karin
title	Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica
title_short	Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica
title_full	Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica
title_fullStr	Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica
title_full_unstemmed	Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica
title_sort	evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica
publisher	Sociedad Médica de Santiago
publishDate	2005
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000500001
work_keys_str_mv	AT papapietrovkarin evoluciondecomorbilidadesmetabolicasasociadasaobesidaddespuesdecirugiabariatrica AT diazgemma evoluciondecomorbilidadesmetabolicasasociadasaobesidaddespuesdecirugiabariatrica AT csendesjattila evoluciondecomorbilidadesmetabolicasasociadasaobesidaddespuesdecirugiabariatrica AT diazjjuancarlos evoluciondecomorbilidadesmetabolicasasociadasaobesidaddespuesdecirugiabariatrica AT braghettomitalo evoluciondecomorbilidadesmetabolicasasociadasaobesidaddespuesdecirugiabariatrica AT burdilesppatricio evoluciondecomorbilidadesmetabolicasasociadasaobesidaddespuesdecirugiabariatrica AT maluendagfernando evoluciondecomorbilidadesmetabolicasasociadasaobesidaddespuesdecirugiabariatrica AT rojascjorge evoluciondecomorbilidadesmetabolicasasociadasaobesidaddespuesdecirugiabariatrica
_version_	1718436202960388096

Evolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica

Ejemplares similares